Know Cancer

or
forgot password
  • cancer clinical trials in brighton, MA

  • Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Esophageal Cancer, Gastric Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    Caritas St. Elizabeth Hospital
    Brighton, Massachusetts 02135
    Primary Progressive Multiple Sclerosis
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Lung Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
    St. Elizabeth's Medical Center of Boston
    Brighton, Massachusetts 02135
    Prostate Cancer
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Lung Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Pancreatic Cancer
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Ovarian Neoplasms
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Malignant Mesothelioma
    S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Lung Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    VEGF Gene Transfer for Critical Limb Ischemia
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Critical Limb Ischemia, Ischemia, Leg Ulcer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Atrial Fibrillation, Atrial Flutter
    Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
    Caritas St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Carcinoma, Non-Small-Cell Lung
    Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy
    Caritas St. Elizabeth Medical Center
    Brighton, Massachusetts 02135
    Colorectal Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Caritas Saint Elizabeth's Medical Center
    Brighton, Massachusetts 02135-2997
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve Block
    St. Elizabeth's Medical Center of Boston
    Brighton, Massachusetts 02135
    Prostate CA